Pharmacist's Guide to CBD Oil

Natalie M. Treese, MBA, PharmD; Mia Flowers, PharmD Candidate 2020

Disclosures

US Pharmacist. 2020;45(3):20-23. 

In This Article

Abstract and Introduction

Abstract

Cannabidiol (CBD) is becoming more prevalent, and pharmacists must be knowledgeable about these products in order to counsel patients effectively. CBD laws and regulations are determined at the state level in the United States. Non–FDA-approved CBD products are not regulated and may contain harmful chemicals. Pharmacists must counsel patients on where and how to obtain products and to check the amount of CBD and delta-9-tetrahydrocannabinol in the product. CBD has numerous drug interactions that should be evaluated by a pharmacist. CBD is most promising for treatment-resistant seizures, and more research is necessary to evaluate its use for other indications. Sativex is currently being investigated in the U.S. for treatment of spasticity associated with multiple sclerosis and schizophrenia. In general, more studies of CBD are needed.

Introduction

Cannabidiol (CBD) is gaining popularity across the United States. Pharmacists must be able to answer patients' questions about CBD and make recommendations. This article will provide specific information about CBD, including laws, how to select a non–FDA-approved CBD product, indications for use, side effects and warnings, drug interactions, dosing and directions, pharmacokinetics, and the future of CBD oil. After reading this article, pharmacists should feel confident about counseling patients about CBD and recommending CBD products.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....